Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Tullis, Elizabeth" or (type any "bookEditor journalEditor issueEditor" and editor="Tullis...

Add to list
- Journal Article
- A1
- open access
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials

Ahmet Z Uluer, Gordon MacGregor, Pilar Azevedo, Veronica Indihar, Claire Keating, Marcus A Mall, Edward F McKone, Bonnie W Ramsey, Steven M Rowe, Ronald C Rubenstein, et al.

(2023) LANCET RESPIRATORY MEDICINE. 11(6). p.550-562
Add to list
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR : a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, Jamie Duckers, Gordon MacGregor, Elizabeth Tullis, Eva Van Braeckel (UGent) , Claire E Wainwright, Danie Watson, Neil Ahluwalia, et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(3). p.267-277
Add to list
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

Harry GM Heijerman, Edward F McKone, Damian G Downey, Eva Van Braeckel (UGent) , Steven M Rowe, Elizabeth Tullis, Marcus A Mall, John J Welter, Bonnie W Ramsey, Charlotte M Mckee, et al.

(2019) LANCET. 394(10212). p.1940-1948
Add to list
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton, Marcus A. Mall, Pavel Dřevínek, Larry C. Lands, Edward F. McKone, Deepika Polineni, Bonnie W. Ramsey, Jennifer L. Taylor-Cousar, Elizabeth Tullis, François Vermeulen, et al.

(2019) NEW ENGLAND JOURNAL OF MEDICINE. 381(19). p.1809-1819
Add to list
VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles

Dominic Keating, Gautham Marigowda, Lucy Burr, Cori Daines, Marcus A Mall, Edward F McKone, Bonnie W Ramsey, Steven M Rowe, Laura A Sass, Elizabeth Tullis, et al.

(2018) NEW ENGLAND JOURNAL OF MEDICINE. 379(17). p.1612-1620

Academic Bibliography

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR : a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation : a double-blind, randomised, phase 3 trial

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles

Contents

Support

Contact